BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38573436)

  • 41. Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study.
    Akyea RK; Qureshi N; Kai J; de Lusignan S; Sherlock J; McGee C; Weng S
    BJGP Open; 2020 Dec; 4(5):. PubMed ID: 33144363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board].
    Walma EP; Visseren FL; Jukema JW; Kastelein JJ; Hoes AW; Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Jan; 150(1):18-23. PubMed ID: 16440619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progress in the care of familial hypercholesterolaemia: 2016.
    Bell DA; Watts GF
    Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries.
    Florentin M; Kostapanos MS; Elisaf MS; Liberopoulos EN
    Curr Pharm Des; 2018; 24(31):3605-3615. PubMed ID: 30306861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
    Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
    Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
    Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
    Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
    Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
    BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of Familial Hypercholesterolaemia in Acute Coronary Syndrome Patients in a Large Regional Coronary Care Unit.
    Samuel R; Birdsey G; Amerena J
    Heart Lung Circ; 2021 May; 30(5):730-733. PubMed ID: 33132051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment.
    Chua YA; Razman AZ; Ramli AS; Mohd Kasim NA; Nawawi H
    J Atheroscler Thromb; 2021 Oct; 28(10):1095-1107. PubMed ID: 33455995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving detection and management of familial hypercholesterolaemia in Australian general practice.
    Brett T; Chan DC; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Condon C; Sheil B; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Watts GF
    Heart; 2021 Jul; 107(15):1213-1219. PubMed ID: 34016696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.
    Qureshi N; Weng S; Tranter J; El-Kadiki A; Kai J
    BMJ Open; 2016 May; 6(5):e011734. PubMed ID: 27231005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".
    Pang J; Chan DC; Hu M; Muir LA; Kwok S; Charng MJ; Florkowski CM; George PM; Lin J; Loi DD; Marais AD; Nawawi HM; Gonzalez-Santos LE; Su TC; Truong TH; Santos RD; Soran H; Tomlinson B; Yamashita S; Ademi Z; Watts GF
    J Clin Lipidol; 2019; 13(2):287-300. PubMed ID: 30797720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population.
    Abdul-Razak S; Rahmat R; Mohd Kasim A; Rahman TA; Muid S; Nasir NM; Ibrahim Z; Kasim S; Ismail Z; Abdul Ghani R; Sanusi AR; Rosman A; Nawawi H
    BMC Cardiovasc Disord; 2017 Oct; 17(1):264. PubMed ID: 29037163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry.
    Pang J; Sullivan DR; Hare DL; Colquhoun DM; Bates TR; Ryan JDM; Bishop W; Burnett JR; Bell DA; Simons LA; Mirzaee S; Kostner KM; Nestel PJ; Wilson AM; O'Brien RC; Janus ED; Clifton PM; Ardill JJ; Chan DC; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2021 Mar; 30(3):372-379. PubMed ID: 32873489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detecting familial hypercholesterolaemia in general practice.
    Kirke A; Watts GF; Emery J
    Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practices in Poland.
    Chlebus K; Cybulska B; Gruchała M; Smaga A; Wróbel K; Wojtyniak B; Pajkowski M; Jankowski P; Zdrojewski T
    Kardiol Pol; 2018; 76(6):960-967. PubMed ID: 29399758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the role as gatekeeper still feasible? A survey among Dutch general practitioners.
    Wammes JJ; Jeurissen PP; Verhoef LM; Assendelft WJ; Westert GP; Faber MJ
    Fam Pract; 2014 Oct; 31(5):538-44. PubMed ID: 25135953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.